USD
$0.00
(0.00%
)At Close (As of Oct 24, 2025)
$22.78M
Market Cap
-
P/E Ratio
-5.26
EPS
$10.00
52 Week High
$3.80
52 Week Low
HEALTHCARE
Sector
| Field | Value (CNY) |
|---|---|
| Gross Profit | -$79M |
| Total Revenue | $384M |
| Cost Of Revenue | $463M |
| Costof Goods And Services Sold | $463M |
| Operating Income | -$532M |
| Selling General And Administrative | $404M |
| Research And Development | - |
| Operating Expenses | $453M |
| Investment Income Net | - |
| Net Interest Income | -$179M |
| Interest Income | $14M |
| Interest Expense | $193M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $131M |
| Income Before Tax | -$670M |
| Income Tax Expense | -$18M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$652M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$476M |
| Ebitda | -$346M |
| Net Income | -$308M |
| Field | Value (CNY) |
|---|---|
| Total Assets | $6.7B |
| Total Current Assets | $984M |
| Cash And Cash Equivalents At Carrying Value | $216M |
| Cash And Short Term Investments | $216M |
| Inventory | $33M |
| Current Net Receivables | $51M |
| Total Non Current Assets | $5.7B |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $680M |
| Intangible Assets Excluding Goodwill | $680M |
| Goodwill | $572M |
| Investments | - |
| Long Term Investments | $472M |
| Short Term Investments | $135M |
| Other Current Assets | $549M |
| Other Non Current Assets | - |
| Total Liabilities | $5.1B |
| Total Current Liabilities | $2.1B |
| Current Accounts Payable | $199M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $1.1B |
| Total Non Current Liabilities | $3B |
| Capital Lease Obligations | $184M |
| Long Term Debt | $2.7B |
| Current Long Term Debt | $1B |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $3.9B |
| Other Current Liabilities | $767M |
| Other Non Current Liabilities | $3.3M |
| Total Shareholder Equity | -$2.3B |
| Treasury Stock | - |
| Retained Earnings | -$4.4B |
| Common Stock | $105K |
| Common Stock Shares Outstanding | $146K |
| Field | Value (CNY) |
|---|---|
| Operating Cashflow | -$398M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $131M |
| Capital Expenditures | $411M |
| Change In Receivables | - |
| Change In Inventory | $6.5M |
| Profit Loss | - |
| Cashflow From Investment | -$593M |
| Cashflow From Financing | $1.1B |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$652M |
| Field | Value (CNY) |
|---|---|
| Gross Profit | -$79M |
| Total Revenue | $384M |
| Cost Of Revenue | $463M |
| Costof Goods And Services Sold | $463M |
| Operating Income | -$532M |
| Selling General And Administrative | $404M |
| Research And Development | - |
| Operating Expenses | $453M |
| Investment Income Net | - |
| Net Interest Income | -$179M |
| Interest Income | $14M |
| Interest Expense | $193M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $131M |
| Income Before Tax | -$670M |
| Income Tax Expense | -$18M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$652M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$476M |
| Ebitda | -$346M |
| Net Income | -$308M |
| Field | Value |
|---|---|
| Ex Dividend Date | 2015-12-23 |
| Declaration Date | None |
| Record Date | None |
| Payment Date | None |
| Amount | 0.98 |
Sector: HEALTHCARE
Industry: MEDICAL CARE FACILITIES
Concord Medical Services Holdings Limited is a leading provider of radiotherapy and diagnostic imaging services in the People's Republic of China, strategically addressing the growing demand for advanced cancer treatment solutions. Headquartered in Beijing, the company operates a comprehensive network of centers that not only enhance patient access to high-quality diagnostic and therapeutic services but also leverage state-of-the-art technologies in the field. With a commitment to improving healthcare outcomes and expanding its service offerings, Concord Medical is well-positioned to capitalize on the burgeoning healthcare market in China.